wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37913356-0AFA7512-D88A-4CB1-9DB0-CCD9BA202E4F
Q37913356-0AFA7512-D88A-4CB1-9DB0-CCD9BA202E4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37913356-0AFA7512-D88A-4CB1-9DB0-CCD9BA202E4F
Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.
P2860
Q37913356-0AFA7512-D88A-4CB1-9DB0-CCD9BA202E4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37913356-0AFA7512-D88A-4CB1-9DB0-CCD9BA202E4F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
31a240cfa73e62be95cbf00d8794c3609f63e1fe
P2860
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.